Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (81-90 of 235) with videos related to

Pageof 24
Sort By:
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Mdm2 and p53 are highly conserved from placozoans to manDavid P Lane, Chit Fang Cheok, Christopher Brown, et al.
Cancer Research|July 21, 2018
The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 TumorsDiana Spiegelberg, Anja C Mortensen, Sara Lundsten, et al.
FEBS Letters|September 26, 2002
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2Dimitris P Xirodimas, June Chisholm, Joana M S Desterro, et al.
Cancer Research|November 3, 2025
Editor's Note: The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 TumorsDiana Spiegelberg, Anja C Mortensen, Sara Lundsten, et al.
Journal of Chemical Theory and Computation|November 24, 2015
Characterization of the Ligand Receptor Encounter Complex and Its Potential for in Silico Kinetics-Based Drug DevelopmentKarim M ElSawy, Reidun Twarock, David P Lane, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunitCampbell McInnes, Martin J I Andrews, Daniella I Zheleva, et al.
Cell|July 10, 2004
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activityDimitris P Xirodimas, Mark K Saville, Jean-Christophe Bourdon, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Detecting and quantifying p53 isoforms at mRNA level in cell lines and tissuesMarie P Khoury, Virginie Marcel, Kenneth Fernandes, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Detecting p53 isoforms at protein levelVirginie Marcel, Marie P Khoury, Kenneth Fernandes, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulationShubhra Ghosh Dastidar, Devanathan Raghunathan, Judith Nicholson, et al.
Pageof 24

Showing results (81-90 of 235) with videos related to

Sort By:
Pageof 24
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Mdm2 and p53 are highly conserved from placozoans to manDavid P Lane, Chit Fang Cheok, Christopher Brown, et al.
Cancer Research|July 21, 2018
The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 TumorsDiana Spiegelberg, Anja C Mortensen, Sara Lundsten, et al.
FEBS Letters|September 26, 2002
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2Dimitris P Xirodimas, June Chisholm, Joana M S Desterro, et al.
Cancer Research|November 3, 2025
Editor's Note: The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 TumorsDiana Spiegelberg, Anja C Mortensen, Sara Lundsten, et al.
Journal of Chemical Theory and Computation|November 24, 2015
Characterization of the Ligand Receptor Encounter Complex and Its Potential for in Silico Kinetics-Based Drug DevelopmentKarim M ElSawy, Reidun Twarock, David P Lane, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Peptidomimetic design of CDK inhibitors targeting the recruitment site of the cyclin subunitCampbell McInnes, Martin J I Andrews, Daniella I Zheleva, et al.
Cell|July 10, 2004
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activityDimitris P Xirodimas, Mark K Saville, Jean-Christophe Bourdon, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Detecting and quantifying p53 isoforms at mRNA level in cell lines and tissuesMarie P Khoury, Virginie Marcel, Kenneth Fernandes, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2012
Detecting p53 isoforms at protein levelVirginie Marcel, Marie P Khoury, Kenneth Fernandes, et al.
Cell Cycle (Georgetown, Tex.)|December 31, 2010
Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulationShubhra Ghosh Dastidar, Devanathan Raghunathan, Judith Nicholson, et al.
Pageof 24